LESLIE THELEN: Open Payments
NPI 1558142554 · WESTPHALIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 67 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $752 · 2025 $1,243
Food & beverage: $1,148Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $564 |
| Janssen Biotech, Inc. | 6 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $137 |
| Gilead Sciences, Inc. | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $48 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Ardelyx, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Celltrion USA Inc. | 1 | $22 |
Products named: RINVOQ, CREON, TREMFYA, XIFAXAN, DUPIXENT, LINZESS, OMVOH, REZDIFFRA.
Industry payments across MI — which companies pay providers there.
